The effect of herbal supplement in type 2 diabetes treatment.

Phase 3

• Conditions: Diabetes.; Diabetes mellitus; E10-E14

• Registration Number: IRCT201109207602N1
• Lead Sponsor: Iran's National Elites Foundation (INEF)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

newly diagnosed diabetes according to ADA 2014 (FPG=>126 mg/dl or HgA1C=>6.4% or BS=>200 mg/dl after OGTT or random BS =>200 and hyperglycemic symptoms); age 30-65 years; signed consent form.
Exclusion criteria: Diabetes type 1; insulin injection during 8 weeks ago; serious infectious diseases; renal failure (GFR< 50 cc/min/); liver failure ( high ALTor/and AST more than 3 times above normal range); cardiac failure; pregnancy and/or breast feeding; past history of seizure or epilepsy.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood Glucose. Timepoint: In the beginning and at the end of 4th and 8th weeks of the trial. Method of measurement: Blood test.

Secondary Outcome Measures

Name	Time	Method
Blood insulin. Timepoint: In the beginning and at the end of 4th and 8th weeks of the trial. Method of measurement: Blood test.;Cholesterol and triglyceride. Timepoint: In the beginning and at the end of 8th week of the trial. Method of measurement: Blood test.